Enhancement of antitumor drug cytotoxicity via laser photoactivation.
We investigate the efficacy of daunomycin, some imino- and amino-substituted daunomycin analogues and the disubstituted aminoanthracenedione, mitoxantrone, in photosensitizing short-term cell kill upon irradiation in the long wavelength visible range, during incubation of Fisher rat thyroid cells with the drugs. While all compounds exhibit similar cytocidal effects on our cell line, in the absence of irradiation, administering 86 J/cm2 at wavelengths either coincident or close to drug absorption peaks causes greater enhancement in cell mortality for the 4-demethoxydaunomycin analogues than either the parent drug or its 5-imino-derivative. A lower enhancement is observed with mitoxantrone. In particular, C50 doses (i.e. concentrations that would kill 50% cells) as low as approximately 10(-9) M are found for both 6- and 11-amino 4-demethoxydaunomycin, compared with the values obtained in the absence of light, which are 2.59 x 10(-4) and 0.43 x 10(-4) M, respectively. Our previous studies of the photophysical and photochemical properties of the excited states of these drugs, and ESR and spin trapping studies of photosensitized generation of singlet oxygen, which were extended in this work to include mitoxantrone, indicate that the cytocidal effects proceed via type I rather than type II mechanisms.
Andreoni
A
A
Dipartimento di Biologia e Patologia Cellulare e Molecolare, University of Naples, Italy.
Colasanti
A
A
Malatesta
V
V
Riccio
P
P
Roberti
G
G
D000818:Animals; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects / Q000528:radiation effects*; D003630:Daunorubicin / Q000031:analogs & derivatives* / Q000494:pharmacology*; D007834:Lasers; D008942:Mitoxantrone / Q000494:pharmacology; D011838:Radiation-Sensitizing Agents; D051381:Rats; D013329:Structure-Activity Relationship; D013961:Thyroid Gland
D011838:Radiation-Sensitizing Agents; D008942:Mitoxantrone; D003630:Daunorubicin